Mace Rothenberg
Vermögen: 748 233 $ am 31.05.2026
Vermögen: 748 233 $ am 31.05.2026
Mace L.
Rothenberg is currently Director at Pancreatic Cancer Action Network, Inc. since 2023; Director at Surrozen Operating, Inc., Tango Therapeutics Sub, Inc., Aulos Bioscience, Inc., and Independent Director at Tango Therapeutics, Inc. and Surrozen, Inc., all since 2021.
Also holds membership at the American Society of Clinical Oncology, Inc. and the American College of Physicians.
Formerly Director at CEO Roundtable on Cancer, Inc. and Chief Medical Officer & Head-Worldwide Medical at Pfizer Inc. from 2019 to 2021.
Education includes undergraduate studies at the University of Pennsylvania and a doctorate from New York University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC. 0,02 % | 05.06.2026 | 31 250 ( 0,02 % ) | 686 875 $ | 31.05.2026 |
SURROZEN INC 0,02 % | 13.05.2026 | 2 341 ( 0,02 % ) | 61 358 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SURROZEN, INC. | Direktor/Vorstandsmitglied | 01.04.2021 |
| TANGO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2021 |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Direktor/Vorstandsmitglied | 24.03.2021 |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm | Direktor/Vorstandsmitglied | 30.03.2021 |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direktor/Vorstandsmitglied | 06.05.2021 |
American College of Physicians
American College of Physicians Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Direktor/Vorstandsmitglied | 01.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Physicians
American College of Physicians Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization | Commercial Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Surrozen, Inc.
Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen